Singapore · Delayed Price · Currency is SGD AsiaMedic Statistics
Total Valuation
AsiaMedic has a market cap or net worth of SGD 21.46 million. The enterprise value is 34.90 million.
| Market Cap | 21.46M |
| Enterprise Value | 34.90M |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AsiaMedic has 1.13 billion shares outstanding. The number of shares has decreased by -0.67% in one year.
| Current Share Class | 1.13B |
| Shares Outstanding | 1.13B |
| Shares Change (YoY) | -0.67% |
| Shares Change (QoQ) | -2.17% |
| Owned by Insiders (%) | 15.75% |
| Owned by Institutions (%) | n/a |
| Float | 485.80M |
Valuation Ratios
The trailing PE ratio is 20.21.
| PE Ratio | 20.21 |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | 23.25 |
| P/OCF Ratio | 6.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.79, with an EV/FCF ratio of 37.80.
| EV / Earnings | 32.45 |
| EV / Sales | 1.07 |
| EV / EBITDA | 8.79 |
| EV / EBIT | 51.86 |
| EV / FCF | 37.80 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 1.25.
| Current Ratio | 1.79 |
| Quick Ratio | 1.65 |
| Debt / Equity | 1.25 |
| Debt / EBITDA | 5.52 |
| Debt / FCF | 21.64 |
| Interest Coverage | 0.40 |
Financial Efficiency
Return on equity (ROE) is 0.91% and return on invested capital (ROIC) is 0.69%.
| Return on Equity (ROE) | 0.91% |
| Return on Assets (ROA) | 0.56% |
| Return on Invested Capital (ROIC) | 0.69% |
| Return on Capital Employed (ROCE) | 0.92% |
| Revenue Per Employee | 833,160 |
| Profits Per Employee | 27,576 |
| Employee Count | 39 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 81.70 |
Taxes
| Income Tax | -4,177 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.33% in the last 52 weeks. The beta is 0.13, so AsiaMedic's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +58.33% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 45.92 |
| Average Volume (20 Days) | 403,490 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AsiaMedic had revenue of SGD 32.49 million and earned 1.08 million in profits. Earnings per share was 0.00.
| Revenue | 32.49M |
| Gross Profit | 7.44M |
| Operating Income | 322,445 |
| Pretax Income | 129,410 |
| Net Income | 1.08M |
| EBITDA | 1.08M |
| EBIT | 322,445 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 8.60 million in cash and 19.98 million in debt, giving a net cash position of -11.38 million or -0.01 per share.
| Cash & Cash Equivalents | 8.60M |
| Total Debt | 19.98M |
| Net Cash | -11.38M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 16.04M |
| Book Value Per Share | 0.01 |
| Working Capital | 6.72M |
Cash Flow
In the last 12 months, operating cash flow was 3.46 million and capital expenditures -2.53 million, giving a free cash flow of 923,195.
| Operating Cash Flow | 3.46M |
| Capital Expenditures | -2.53M |
| Free Cash Flow | 923,195 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 22.91%, with operating and profit margins of 0.99% and 3.31%.
| Gross Margin | 22.91% |
| Operating Margin | 0.99% |
| Pretax Margin | 0.40% |
| Profit Margin | 3.31% |
| EBITDA Margin | 3.31% |
| EBIT Margin | 0.99% |
| FCF Margin | 2.84% |
Dividends & Yields
AsiaMedic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.67% |
| Shareholder Yield | 0.67% |
| Earnings Yield | 5.01% |
| FCF Yield | 4.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AsiaMedic has an Altman Z-Score of 0.63 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.63 |
| Piotroski F-Score | 7 |